Genetic alterations and methods of use thereof for the diagnosis and treatment of type I diabetes
US10125395B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 18, 2012 |
| Grant date | Nov 13, 2018 |
| Priority date | — |
| Expiry date | Oct 18, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for the diagnosis and treatment of T1D are disclosed. More specifically, the invention provides gene targets containing single nucleotide polymorphisms associated with this disease. Methods and kits for using the sequences so identified for diagnostic and therapeutic purposes are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.